Adela Navratilova
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Serum IL-40 is elevated in systemic sclerosis and is linked to disease activity, gastrointestinal involvement, immune regulation and fibrotic processes.
Journal: Arthritis research & therapy
Published: November 22, 2024
IL-40 is up-regulated in the synovial fluid and cartilage of osteoarthritis patients and contributes to the alteration of chondrocytes phenotype in vitro.
Journal: Arthritis research & therapy
Published: February 26, 2024
Dexamethasone nanomedicines with optimized drug release kinetics tailored for treatment of site-specific rheumatic musculoskeletal diseases.
Journal: International journal of pharmaceutics
Published: January 22, 2024
Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650.
Journal: Biomedicines
Published: September 23, 2023
Interleukin-37: associations of plasma levels and genetic variants in gout.
Journal: Arthritis research & therapy
Published: April 06, 2023
New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis.
Journal: RMD open
Published: November 29, 2022
IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis.
Journal: Frontiers in immunology
Published: July 22, 2021
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin.
Journal: Biomedicines
Published: May 11, 2021
S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils.
Journal: Scientific reports
Published: May 02, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026